CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MHRA (UK)
High ImpactOriginal article

MHRA approves catumaxomab to treat cancer-related fluid build-up in the abdomen 

RegulatoryapprovedcatumaxomabPositive
AI Analysis

Summary

The MHRA has approved catumaxomab for treating cancer-related fluid accumulation in the abdomen. The agency will continue to monitor the drug's safety and effectiveness post-approval.

Outcome Details

MHRA approval for catumaxomab to treat malignant ascites

Importance:8/10
Sentiment:
0.80
regulatory approvalMHRAoncologycatumaxomab

Read the original article

Published by MHRA (UK) on October 7, 2026 2:43 PM

Read Original